Ym bio sciences inc. – product pipeline review – 2012
Aarkstore.com announces, The Latest market research report is available inits vast collection:YM BioSciences Inc. – Product Pipeline Review – 2012More about this reportYou can also request for sample page of above mention reports email@example.comSummaryGlobal Markets Direct’s pharmaceuticals report, “YM BioSciences Inc. - ProductPipeline Review - 2012” provides data on the YM BioSciences Inc.’s research anddevelopment focus. The report includes information on current developmentalpipeline, complete with latest updates, and features on discontinued and dormantprojects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, YM BioSciences Inc.’s corporate website, SEC filings, investorpresentations and featured press releases, both from YM BioSciences Inc. andindustry-specific third party sources, put together by Global Markets Direct’s team.Scope- YM BioSciences Inc. - Brief YM BioSciences Inc. overview including businessdescription, key information and facts, and its locations and subsidiaries.- Review of current pipeline of YM BioSciences Inc. human therapeutic division.- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.
Table of contents:List of Tables 5List of Figures 5YM BioSciences Inc. Snapshot 6YM BioSciences Inc. Overview 6Key Information 6Key Facts 6YM BioSciences Inc. – Research and Development Overview 7Key Therapeutic Areas 7YM BioSciences Inc. – Pipeline Review 10Pipeline Products by Stage of Development 10Pipeline Products – Monotherapy 11Pipeline Products – Combination Treatment Modalities 12YM BioSciences Inc. – Pipeline Products Glance 13YM BioSciences Inc. – Late Stage Pipeline 13Phase III Products/Combination Treatment Modalities 13YM BioSciences Inc. Clinical Stage Pipeline Products 14Phase II Products/Combination Treatment Modalities 14Phase I Products/Combination Treatment Modalities 15YM BioSciences Inc. – Drug Profiles 16Biomab EGFR 16Product Description 16Mechanism of Action 16R&D Progress 16Cisplatin + Vinorelbine + Nimotuzumab 18Product Description 18Mechanism of Action 18R&D Progress 18CYT-997 19Product Description 19Mechanism of Action 19R&D Progress 19CYT387 20Product Description 20Mechanism of Action 20
R&D Progress 20Nimotuzumab + Cisplatin 21Product Description 21Mechanism of Action 21R&D Progress 21Nimotuzumab + Docetaxel + Carboplatin 23Product Description 23Mechanism of Action 23R&D Progress 23Nimotuzumab + Gemcitabine 24Product Description 24List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview – 2012&PubId=&pagenum=1MacroGenics, Inc. – Product Pipeline Review – 2012TopoTarget A/S – Product Pipeline Review – 2012YM BioSciences Inc. – Product Pipeline Review – 2012ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012
Acucela Inc. – Product Pipeline Review – 2012Aldagen, Inc. – Product Pipeline Review – 2012Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: firstname.lastname@example.org